Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients

NCT01611727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

BRCA1 Mutation
Metastatic Breast Cancer

Interventions

DRUG: Cisplatin

Sponsor

Pomeranian Medical University Szczecin

Collaborators

[object Object]